A drug that is used to treat myelodysplastic syndromes and is being studied in the treatment of other types of cancer. It belongs to the family of drugs called antimetabolites. Also called Mylosar and Vidaza.
Last updated: 2016-01-06
Source: The National Cancer Institute's Dictionary of Cancer Terms (http://www.cancer.gov/dictionary)